Emodin targets the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: enzymatic inhibition assay with crystal structural and thermodynamic characterization
详细信息 查看全文
- 作者：Jing Chen (1)
Liang Zhang (1)
Yu Zhang (1)
Haitao Zhang (1)
Jiamu Du (2)
Jianping Ding (2)
Yuewei Guo (1)
Hualiang Jiang (1)
Xu Shen (1) - 刊名：BMC Microbiology
- 出版年：2009
- 出版时间：December 2009
- 年：2009
- 卷：9
- 期：1
- 全文大小：1612KB
- 参考文献：1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. / Lancet 1984, 1:1311-315. CrossRef
2. Cover TL, Blaser MJ:Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. / Adv Intern Med 1996, 41:85-17.
3. Brown LM:Helicobacter pylori : epidemiology and routes of transmission. / Epidemiol Rev 2000, 22:283-97.
4. Ulmer HJ, Beckerling A, Gatz G: Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review. / Helicobacter 2003, 8:95-04. CrossRef
5. Cameron IC, Azmy IA: Thromboprophylaxis in patients undergoing surgery for breast cancer. / Breast 2001, 10:535-37. CrossRef
6. White SW, Zheng J, Zhang YM, Rock : The structural biology of type II fatty acid biosynthesis. / Annu Rev Biochem 2005, 74:791-31. CrossRef
7. Liu W, Luo C, Han C, Peng S, Yang Y, Yue J, Shen X, Jiang H: A new beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Helicobacter pylori : Molecular cloning, enzymatic characterization, and structural modeling. / Biochem Biophys Res Commun 2005, 333:1078-086. CrossRef
8. Zhang L, Liu W, Hu T, Du L, Luo C, Chen K, Shen X, Jiang H: Structural basis for catalytic and inhibitory mechanisms of beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ). / J Biol Chem 2008, 283:5370-379. CrossRef
9. Alves DS, Perez-Fons L, Estepa A, Micol V: Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin. / Biochem Pharmacol 2004, 68:549-61. CrossRef
10. Wang HH, Chung JG: Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. / Curr Microbiol 1997, 35:262-66. CrossRef
11. Chang CH, Lin CC, Yang JJ, Namba T, Hattori M: Anti-inflammatory effects of emodin from ventilago leiocarpa. / Am J Chin Med 1996, 24:139-42. CrossRef
12. Cai J, Razzak A, Hering J, Saed A, Babcock TA, Helton S, Espat NJ: Feasibility evaluation of emodin (rhubarb extract) as an inhibitor of pancreatic cancer cell proliferation in vitro. / JPEN J Parenter Enteral Nutr 2008, 32:190-96. CrossRef
13. Sato M, Maulik G, Bagchi D, Das DK: Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin. / Free Radic Res 2000, 32:135-44. CrossRef
14. Kuo YC, Meng HC, Tsai WJ: Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum Ohwi. / Inflamm Res 2001, 50:73-2. CrossRef
15. Kuo YC, Tsai WJ, Meng HC, Chen WP, Yang LY, Lin CY: Immune reponses in human mesangial cells regulated by emodin from Polygonum hypoleucum Ohwi. / Life Sci 2001, 68:1271-286. CrossRef
16. Lee SU, Shin HK, Min YK, Kim SH: Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression. / Int Immunopharmacol 2008, 8:741-47.
17. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palu G: Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. / Cancer Res 2000, 60:2800-804.
18. Zhang L, Lau YK, Xia W, Hortobagyi GN, Hung MC: Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. / Clin Cancer Res 1999, 5:343-53.
19. Zhang L, Hung MC: Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. / Oncogene 1996, 12:571-76.
20. Jayasuriya H, Koonchanok NM, Geahlen RL, McLaughlin JL, Chang CJ: Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. / J Nat Prod 1992, 55:696-98. CrossRef
21. Lu Y, Zhang J, Qian J: The effect of emodin on VEGF receptors in human colon cancer cells. / Cancer Biother Radiopharm 2008, 23:222-28. CrossRef
22. Chang LC, Sheu HM, Huang YS, Tsai TR, Kuo KW: A novel function of emodin: enhancement of the nucleotide excision repair of UV- and cisplatin-induced DNA damage in human cells. / Biochem Pharmacol 1999, 58:49-7. CrossRef
23. Yim H, Lee YH, Lee CH, Lee SK: Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor. / Planta Med 1999, 65:9-3. CrossRef
24. Leslie AG: Integration of macromolecular diffraction data. / Acta Crystallogr D Biol Crystallogr 1999, 55:1696-702. CrossRef
25. Collaborative Computational Project, Number 4: The CCP4 suite: programs for protein crystallography. / Acta Crystallogr D Biol Crystallogr 1994, 50:760-63. CrossRef
26. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL: Crystallography & NMR system: A new software suite for macromolecular structure determination. / Acta Crystallogr D Biol Crystallogr 1998, 54:905-21. CrossRef
27. Emsley P, Cowtan K: Coot: model-building tools for molecular graphics. / Acta Crystallogr D Biol Crystallogr 2004, 60:2126-132. CrossRef
28. Morris AL, MacArthur MW, Hutchinson EG, Thornton JM: Stereochemical quality of protein structure coordinates. / Proteins 1992, 12:345-64. CrossRef
29. Sharma SK, Kapoor M, Ramya TN, Kumar S, Kumar G, Modak R, Sharma S, Surolia N, Surolia A: Identification, characterization, and inhibition of Plasmodium falciparum beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ). / J Biol Chem 2003, 278:45661-5671. CrossRef
30. Tasdemir D, Lack G, Brun R, Ruedi P, Scapozza L, Perozzo R: Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. / J Med Chem 2006, 49:3345-353. CrossRef
31. Osato MS: Antimicrobial susceptibility testing for Helicobacter pylori : sensitivity test results and their clinical relevance. / Curr Pharm Des 2000, 6:1545-555. CrossRef
32. Lu YJ, White SW, Rock CO: Domain swapping between Enterococcus faecalis FabN and FabZ proteins localizes the structural determinants for isomerase activity. / J Biol Chem 2005, 280:30342-0348. CrossRef
33. Wang H, Cronan JE: Functional replacement of the FabA and FabB proteins of Escherichia coli fatty acid synthesis by Enterococcus faecalis FabZ and FabF homologues. / J Biol Chem 2004, 279:34489-4495. CrossRef
34. Kimber MS, Martin F, Lu Y, Houston S, Vedadi M, Dharamsi A, Fiebig KM, Schmid M, Rock CO: The structure of (3R)-hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Pseudomonas aeruginosa. / J Biol Chem 2004, 279:52593-2602. CrossRef
35. Swarnamukhi PL, Sharma SK, Bajaj P, Surolia N, Surolia A, Suguna K: Crystal structure of dimeric FabZ of Plasmodium falciparum reveals conformational switching to active hexamers by peptide flips. / FEBS Lett 2006, 580:2653-660. CrossRef
36. Kong YH, Zhang L, Yang ZY, Han C, Hu LH, Jiang HL, Shen X: Natural product juglone targets three key enzymes from Helicobacter pylori : inhibition assay with crystal structure characterization. / Acta Pharmacol Sin 2008, 29:870-76. CrossRef
37. Zhang L, Kong Y, Wu D, Zhang H, Wu J, Chen J, Ding J, Hu L, Jiang H, Shen X: Three flavonoids targeting the beta-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori : crystal structure characterization with enzymatic inhibition assay. / Protein Sci 2008, 17:1971-978. CrossRef
38. Velazquez Campoy A, Freire E: ITC in the post-genomic era...? Priceless. / Biophys Chem 2005, 115:115-24. CrossRef - 作者单位：Jing Chen (1)
Liang Zhang (1)
Yu Zhang (1)
Haitao Zhang (1)
Jiamu Du (2)
Jianping Ding (2)
Yuewei Guo (1)
Hualiang Jiang (1)
Xu Shen (1)
1. Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China
2. Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, 200031, PR China - ISSN：1471-2180
文摘
Background The natural product Emodin demonstrates a wide range of pharmacological properties including anticancer, anti-inflammatory, antiproliferation, vasorelaxant and anti-H. pylori activities. Although its H. pylori inhibition was discovered, no acting target information against Emodin has been revealed to date. Results Here we reported that Emodin functioned as a competitive inhibitor against the recombinant β-hydroxyacyl-ACP dehydratase from Helicobacter pylori (HpFabZ), and strongly inhibited the growth of H. pylori strains SS1 and ATCC 43504. Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) based assays have suggested the kinetic and thermodynamic features of Emodin/HpFabZ interaction. Additionally, to inspect the binding characters of Emodin against HpFabZ at atomic level, the crystal structure of HpFabZ-Emodin complex was also examined. The results showed that Emodin inhibition against HpFabZ could be implemented either through its occupying the entrance of the tunnel or embedding into the tunnel to prevent the substrate from accessing the active site. Conclusion Our work is expected to provide useful information for illumination of Emodin inhibition mechanism against HpFabZ, while Emodin itself could be used as a potential lead compound for further anti-bacterial drug discovery.